New Jersey Drug Problems
January 5, 2008
There are approximately 40,000 drug rehab and addiction treatment center admissions in New Jersey each year, however, due to the high relapse rate of many traditional drug rehab programs most families are searching for something that works.
The Solution
Drug rehab and alcohol rehab that addresses the individual through a holistic approach is the most successful method. Our philosophy is to refer you to the best possible drug rehab center that can help handle the problem for good. We will refer you to drug rehab and alcohol rehab programs that will meet each person’s individual needs.
New Jersey Drug Situation
Cocaine is considered a significant drug threat to New Jersey. Powder cocaine is readily available throughout the State and crack cocaine is available in urban population areas. Cocaine is the drug most often associated with violent crime in the State. Cocaine is generally sold in ounce and pound quantities in New Jersey. Crack use is declining but remains available in the larger metropolitan areas of New Jersey.
Club drugs, which are mostly synthetic substances, are increasing in availability and use in New Jersey. LSD in liquid form is readily available in the metropolitan areas of New Jersey. During 2001, 34% of those surveyed in New Jersey reported lifetime usage of MDMA. 4.5% of those surveyed reported usage of MDMA within the past 30 days. The average user age was 17.3, and the average age of first time use was 15.9 years.
Heroin - The most common types of heroin available in New Jersey are Mexican black tar heroin and brown powdered heroin. New heroin users in New Jersey are often young adults who smoke or snort the drug rather than inject it. This is due to a misconception that this practice is safer and less likely to lead to addiction.
Oxycontin and Abuse
October 18, 2007
OxyContin ® Diversion and Abuse
The abuse of oxycodone products in general has increased in recent years. In April 2000, The Journal of the American Medical Association (JAMA) published a study, which examined two data collection sources. The DEA Automation of Reports and Consolidated Orders System (ARCOS) data tracks the distribution of oxycodone and other opioid analgesics and the Drug Abuse Warning Network (DAWN) Medical Examiner (ME) and Emergency Department (ED) data ascertained the health consequences associated with its abuse from 1990 to 1996. The JAMA study found a 23 percent increase in the medical use of oxycodone with no corresponding increase in the illicit abuse of the drug. However, 1998 DAWN ME data reported a 93 percent increase in oxycodone mentions between 1997 and 1998 and the number of oxycodone-related DAWN ED mentions increased 32.4 percent from 1997 (4,857) to 1999 (6,429).
Comments
Contact Us